Court Upholds Acclarent Off-Label Marketing Convictions
Executive Summary
The judge agreed that off-label marketing cases pose some challenges, but said the evidence against the former Acclarent execs was strong.
You may also be interested in...
Fines, But No Prison Time For Ex-Acclarent Execs
The sentences are the latest chapter in a long-running off-label marketing case.
Acclarent Execs Move To Appeal Off-Label Conviction
Attorneys for former Acclarent executives William Facteau and Patrick Fabian have filed a request that their convictions on off-label marketing charges either be set aside or that they be granted a new trial, citing other recent off-label trials and misconduct by the government.
Former Acclarent Execs Convicted Of Misdemeanors In Off-Label Case
Two former executives from J&J's Acclarent division were found not guilty of felony charges but convicted on misdemeanor counts. Prior to being acquired by J&J, Acclarent allegedly marketed its Relieva Stratus sinus dilation device as a steroid-delivery system, even though the FDA had cleared the device only to deliver saline.